Search Results - "Esteghamat, Naseem S"

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center by Othman, Tamer, Moskoff, Benjamin N., Ho, Gwendolyn, Tenold, Matthew E., Azenkot, Tali, Krackeler, Margaret L., Fisch, Samantha C., Potter, Laura A., Kaesberg, Paul R., Welborn, Jeanna L., Wun, Ted, Esteghamat, Naseem S., Hoeg, Rasmus T., Rosenberg, Aaron S., Abedi, Mehrdad, Tuscano, Joseph M., Jonas, Brian A.

“…Hyper-CVAD is an established regimen for adult ALL that was developed at the MD Anderson Cancer Center (MDACC). However, results can vary across different…”
Get full text

Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study by Esteghamat, Naseem S., Brunson, Ann, Rosenberg, Aaron S., Schonfeld, Sara J., Valcarcel, Bryan, Abrahão, Renata, Cooley, Julianne J.P., Meyer, Christa L., Auletta, Jeffery J., Morton, Lindsay M., Muffly, Lori, Wun, Ted, Keegan, Theresa H.M.

“…Autologous hematopoietic cell transplantation (autoHCT) is associated with survival benefits in multiple myeloma (MM), but utilization remains low and differs…”
Get full text

Assessing Time to Diagnosis, End-Organ Damage and Treatment Response in Young Newly Diagnosed Multiple Myeloma Patients by Quan, Michelle A., Ang, Kwan-Keat, Tuscano, Joseph M, Abedi, Mehrdad, Jonas, Brian A., Esteghamat, Naseem S, Welborn, Jeanna L, Kaesberg, Paul R., Rosenberg, Aaron S

Get full text

Healthcare Resource Utilization in Acute Myeloid Leukemia Treatments: Hypomethylating Agent + Venetoclax Vs. High Intensity Regimens by Krackeler, Margaret Li, Moskoff, Benjamin, Othman, Tamer, Azenkot, Tali, Beechinor, Ryan J., Rosenberg, Aaron S, Esteghamat, Naseem S, Hoeg, Rasmus T, Tuscano, Joseph M, Jonas, Brian A.

Get full text

A Phase I Study of Uproleselan Combined with Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients with Treatment Naïve Acute Myeloid Leukemia by Jonas, Brian A., Welborn, Jeanna L, Esteghamat, Naseem S, Hoeg, Rasmus T, Rosenberg, Aaron S, Molnar, Laura, Dang-Chu, Ashley Linh, Stewart, Susan L, Tuscano, Joseph M

Get full text

Utilization of Autologous HCT in Multiple Myeloma: A Novel Linkage of CIBMTR, Cancer Registry and Hospitalization Data in California by Esteghamat, Naseem S, Brunson, Ann M, Wun, Ted, Rosenberg, Aaron S, Cooley, Julianne J.P., Schonfeld, Sara J., Meyer, Christa L., Valcarcel, Bryan, Abrahao, Renata, Auletta, Jeffery, Morton, Lindsay M., Muffly, Lori, Keegan, Theresa H.M.

Get full text

Long-Axial Field-of-View PET Imaging in Patients with Lymphoma by Mingels, Clemens, Nalbant, Hande, Sari, Hasan, Godinez, Felipe, Sen, Fatma, Spencer, Benjamin, Esteghamat, Naseem S., Tuscano, Joseph M., Nardo, Lorenzo

“…[18F]fluoro-2-deoxy-d-glucose PET/computed tomography has been implemented in the management of patients with lymphoma, offering real-time metabolic…”
Get full text

Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities by Mingels, Clemens, Nalbant, Hande, Sari, Hasan, Godinez, Felipe, Sen, Fatma, Spencer, Benjamin, Esteghamat, Naseem S, Tuscano, Joseph M, Nardo, Lorenzo

“…[ F]fluoro-2-deoxy-d-glucose PET/computed tomography has been implemented in the management of patients with lymphoma, offering real-time metabolic information…”
Get full text

Identifying Multiple Myeloma Patients Using Automated Data Capture from Electronic Medical Records by Rosenberg, Aaron S, Riedl, Albert William, Quan, Michelle A., Ang, Kwan-Keat, Tuscano, Joseph M, Esteghamat, Naseem S, Jonas, Brian A., Graff, John, Renquist, Matthew, Cawood, Joseph, Welborn, Jeanna L, Hoeg, Rasmus T, Kaesberg, Paul R., Anderson, Kent, Adams, Jason Y, Keegan, Theresa H.M.

Get full text